logo-loader

Novaliq

Receive alerts
Market:
PRIVATE
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Novaliq is an ophthalmic pharmaceutical company based in Heidelberg, Germany with an office in Cambridge, U.S.

Novaliq’s mission is to transform ocular therapeutics based on EyeSol®, the first and only water-free technology, enhancing the topical bio-availability, stability and safety of traditionally insoluble or unstable drugs.